Management of Patients With Heart Failure at Home After Hospital Discharge
ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Akershus
About this trial
This study aims to assess whether patients with acute heart failure (HF) can achieve the same level of HF-therapies by digital follow-up at home as compared to hospital visits according to the STRONG-HF strategy. Patients admitted to hospital with acute HF will be enrolled and randomized to either follow-up at the hospital out-patient clinic or digital follow-up at home.
Eligibility criteria
Qualifiers
Hospital admission within the 72 hours prior to screening for acute HF.
NT-proBNP ≥ 1,000 pg/mL measured during the hospitalization
Systolic blood pressure ≥ 100 mmHg and of heart rate ≥ 60 bpm within 24 hours before randomization
Serum potassium ≤ 5.0 mEq/L (mmol/L).
Disqualifiers
Age below 18 or above 85 years.
Clearly documented intolerance to high doses of beta-blockers
Clearly documented intolerance to high doses of renin-angiotensin system (RAS) blockers (both ACEi and ARB).
Renal disease or estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73m2 at screening or history of dialysis.
Trial design
Treatments tested in this trial
- Digital follow-up and uptitration of medications at home after hospital discharge for heart failure
- Follow-up and uptitration of medications at the hospital outpatient-clinic after hospital discharge for heart failure
Treatment groups
450 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Hospital, Akershus
Lead sponsor
Oslo University Hospital
Collaborator
Source ClinicalTrials.gov